Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-01-14 GRIFFIN MICHELLE RENEE Director Sale −959 $66.43 $64K 0
2021-01-14 GRIFFIN MICHELLE RENEE Director Option exercise · Stock Option (Right to Buy) −6,000 95,000
2021-01-13 RUBINSTEIN JULIE President Option exercise +15,000 $6.32 $95K 15,000
2021-01-13 RUBINSTEIN JULIE President Sale −8,115 $62.79 $510K 6,885
2021-01-13 RUBINSTEIN JULIE President Sale −6,885 $63.72 $439K 0
2021-01-13 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 260,000
2021-01-13 Cohen Chad M Chief Financial Officer Option exercise +50,000 $6.32 $316K 51,000
2021-01-13 Cohen Chad M Chief Financial Officer Sale −15,820 $62.92 $995K 35,180
2021-01-13 Cohen Chad M Chief Financial Officer Sale −34,180 $63.63 $2.2M 1,000
2021-01-13 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right To Buy) −50,000 365,000
2021-01-12 Cohen Chad M Chief Financial Officer Option exercise +75,000 $6.32 $474K 76,000
2021-01-12 Cohen Chad M Chief Financial Officer Sale −39,973 $62.25 $2.5M 36,027
2021-01-12 Cohen Chad M Chief Financial Officer Sale −33,827 $62.96 $2.1M 2,200
2021-01-12 Cohen Chad M Chief Financial Officer Sale −1,200 $63.73 $76K 1,000
2021-01-12 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right To Buy) −75,000 415,000
2021-01-12 RUBINSTEIN JULIE President Option exercise +15,000 $6.32 $95K 15,000
2021-01-12 RUBINSTEIN JULIE President Sale −9,872 $62.47 $617K 5,128
2021-01-12 RUBINSTEIN JULIE President Sale −5,128 $63.10 $324K 0
2021-01-12 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 275,000
2021-01-11 RUBINSTEIN JULIE President Option exercise +15,000 $6.32 $95K 15,000

Page 73 of 120 · 2,386 trades